A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation-Positive Solid Tumors
published in: Clinical Cancer Research
date of publication: 2019-09-10
Cites articles
There is nothing here
Article - wd:Q90044385